Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
has similarity to immunoglobulins\; expressed in NK cells [RGD, Feb 2006].. Additionally we are shipping NCR1 Proteins (18) and NCR1 Kits (8) and many more products for this protein.
Showing 10 out of 218 products:
Mouse (Murine) Polyclonal NCR1 Primary Antibody for FACS - ABIN4896491
Ostermann, Tuddenham, Macquin, Alsaleh, Schreiber-Becker, Tanguy, Bahram, Pfeffer, Georgel: Deregulation of type I IFN-dependent genes correlates with increased susceptibility to cytomegalovirus acute infection of dicer mutant mice. in PLoS ONE 2012
Show all 3 references for ABIN4896491
Cow (Bovine) Monoclonal NCR1 Primary Antibody for FACS - ABIN120215
Kulberg, Boysen, Storset: Reference values for relative numbers of natural killer cells in cattle blood. in Developmental and comparative immunology 2004
Show all 3 references for ABIN120215
Human Monoclonal NCR1 Primary Antibody for EIA, FACS - ABIN121147
Pessino, Sivori, Bottino, Malaspina, Morelli, Moretta, Biassoni, Moretta: Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. in The Journal of experimental medicine 1998
Show all 2 references for ABIN121147
Human Monoclonal NCR1 Primary Antibody for FACS - ABIN4898802
Markel, Seidman, Besser, Zabari, Ortenberg, Shapira, Treves, Loewenthal, Orenstein, Nagler, Schachter: Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells. in PLoS ONE 2009
Show all 2 references for ABIN4898802
Human Monoclonal NCR1 Primary Antibody for FACS - ABIN4898805
Kwant-Mitchell, Pek, Rosenthal, Ashkar: Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. in PLoS ONE 2009
Mouse (Murine) Polyclonal NCR1 Primary Antibody for FACS - ABIN4896493
Brauner, Elemans, Lemos, Broberger, Holmberg, Flodström-Tullberg, Kärre, Höglund: Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. in Journal of immunology (Baltimore, Md. : 1950) 2010
Human Polyclonal NCR1 Primary Antibody for ELISA, WB - ABIN1535078
Grimwood, Gordon, Olsen, Terry, Schmutz, Lamerdin, Hellsten, Goodstein, Couronne, Tran-Gyamfi, Aerts, Altherr, Ashworth, Bajorek, Black, Branscomb, Caenepeel, Carrano, Caoile, Chan, Christensen et al.: The DNA sequence and biology of human chromosome 19. ... in Nature 2004
Human Polyclonal NCR1 Primary Antibody for FACS, IF (p) - ABIN1386154
Vindevogel, Baert, VAN Hoylandt, Verbist, Vande Velde, Garg, Agostinis, Vergote, Coosemans: The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer. in Anticancer research 2016
Mouse (Murine) Monoclonal NCR1 Primary Antibody for FACS - ABIN4899668
Wang, Xia, Chen, Huang, Xiong, Liu, Li, Ye, Du, Fan: Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. in Immunity 2016
Intrahepatic NKp46 NK cells exhibited anti-HCV activity via cell-to-cell contact. The variation of the NKp46 proportion in individuals could be attributed to the diversity of HCV resistance observed in these individuals.
Taken together, these results demonstrate that endogenous levels of IFN-alpha (show IFNA Antibodies) secreted by plasmacytoid dendritic cells induce natural killer cells to lyse HIV-1-infected autologous CD4 (show CD4 Antibodies)+ primary T cells via the engagement of NKp46 and NKG2D (show KLRK1 Antibodies).
NKp46 was thus involved in the production of serine proteases and interleukin-22 (show IL22 Antibodies) in human mast cells.
Age and CMV serostatus influence the expression of NKp30 (show NCR3 Antibodies), NKp46 and DNAM-1 (show CD226 Antibodies) activating receptors on resting and IL-2 (show IL2 Antibodies) activated natural killer cells.
Ncr1-Noe proteins accumulate in the endoplasmic reticulum, and that the expression of Ncr1-Noe proteins, but not WT Ncr1, leads to increased Helios (show ZNFN1A2 Antibodies) expression
Data show that regulatory dendritic cells (regDC) restrain IFN-gamma (show IFNG Antibodies) secretion by NK cells through secretion of interleukin-10 (IL-10 (show IL10 Antibodies)), engagement of MHC class I-specific inhibitory receptors, and the activating receptor NKp46.
Expression of NKp46/NCR1 in NK cells was significantly higher in untreated severe aplastic anemia patients than those in remission SAA (show SAA1 Antibodies) and controls. This may be the reason for the hyperfunction of the immune system in SAA (show SAA1 Antibodies) patients.
On CD56 (show NCAM1 Antibodies)(+) CD3 (show CD3 Antibodies)(-) cells, NKp44 (show NCR2 Antibodies) and NKp46 expressions were high in the acute hepatitis E patients, whereas NKp30 (show NCR3 Antibodies), NKp44 (show NCR2 Antibodies), NKp46 and NKG2D (show KLRK1 Antibodies) were high in the recovered individuals.
Downregulated NKG2D (show KLRK1 Antibodies), NKp46, and DNAM-1 (show CD226 Antibodies) receptors associated with impaired NK cell effector function are important biomarkers of advanced disease with a poor prognosis in melanoma patients.
Women, w/ or w/o endometriosis, having larger populations of cytotoxic CD16 (show CD16 Antibodies)(+) uterine NK cells and/or higher populations of NKp46(+)CD56 (show NCAM1 Antibodies)(+) cells may be at greater risk of infertility resulting from inflammatory environment during implantation or later
Rag knockout mice that possess fully functional NKp46(+) cells
NK cell receptor (show KLRD1 Antibodies) NKp46 regulates graft-versus-host disease.
Ifnar1 (show IFNAR1 Antibodies)(-/-) T cells had elevated expression of natural cytotoxicity triggering receptor 1 (NCR1) ligands upon infection, rendering them targets for NCR1 mediated NK cell attack.
Data from knockout/transgenic mice suggest that activation of Ncr1 by endogenous (as yet undefined) ligands contributes to activation/maturation of uterine natural killer cells and likely makes critical contributions to implantation/placentation.
Here, we demonstrate the regulation of T-cell mediated allergic responses, which is dependent on the NK-cell specific receptor NKp46 (Ncr1 in mice).
NKp46 deficiency alone, or in combination with NKG2D (show KLRK1 Antibodies) deficiency, had no effect on frequency or function of NK cells
NCR1 and NKp46 directly recognize a periodontal pathogen.
NKp46/NCR1 plays an important role in controlling neoplasm metastasis
downregulation of NK activity by NKp46 associated with silencing of Helios (show ZNFN1A2 Antibodies) in NK cells; NKp46 critical for development of antiviral and antibacterial T cell response
has similarity to immunoglobulins\; expressed in NK cells
NK cell-activating receptor
, lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46)
, natural killer cell p46-related protein
, MAR1 (mouse activating receptor 1)
, activating receptor 1
, lymphocyte antigen 94
, NK receptor KILR-1
, lymphocyte antigen 94 homolog (activating NK-receptor
, rat-activating receptor 1